Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Articles — Page 822
Holdings Stock Rallied Thursday as Arm Stock Surged
A strong one-day move lifted ARM stock on Thursday after an upbeat price target and bullish analyst commentary. This ...
Should Meta Platforms Stock Be a Buy If It Falls Below $600?
Meta Platforms has hovered around a pivotal level. This guide weighs the pros, cons, and real-world steps to decide i...
Time Rivian Stock Deliveries Arrive: Should You Buy?
Rivian is rolling out its smaller R2 SUV, and deliveries have begun. As investors watch the headlines, the big questi...
SpaceX Lockup Period: What Investors Should Know Now
SpaceX's move toward a public market future brings questions about lockups. This guide explains spacex lockup period:...
Reasons Touching SpaceX's IPO: Four Investor Cautions
SpaceX's IPO hype is hard to ignore, but there are four solid concerns investors should weigh before buying in. This ...
This Year. Here's What History Suggests for Investors
The S&P 500 is up this year, but history offers guidance on what comes next. Learn the patterns, risks, and practical...
Shell’s Warns That Prices Could Rise: Investor Guide
Oil markets face a persistent pricing regime, per Shell’s warning. This guide translates that view into practical inv...
Jones Climb Thursday Wall Street Rebounds Before SpaceX IPO
After a short three-day drift, major averages regained their footing on Thursday. The Dow, S&P 500, and NASDAQ logged...
Billionaire Baron Believes SpaceX Could Hit $30T by 2040
A legendary investor speculates SpaceX could reach $30 trillion by 2040. This piece breaks down what that would requi...
Will SpaceX Years? Here's What Experts Say About Growth
The next five years could redefine SpaceX’s place in markets from launches to internet services. This guide breaks do...
ASML Holding Stock Popped: Why It Jumped Today for Investors
ASML Holding stock popped today as investors weighed AI-driven demand, backlog strength, and a brighter outlook for c...